CyteGen is a biotechnology company focused on extending human healthspan by addressing age-related diseases. Their proprietary platform identifies molecules that promote the removal of damaged mitochondria and the creation of new, healthy ones, aiming to enhance cellular metabolism. Founded in 2014 and based in Shorewood, Wisconsin, CyteGen operates as a privately held, venture capital-backed entity.